Interferon-γ-mediated inhibition of cyclin A gene transcription is independent of Individual cis-acting elements in the cyclin a promoter

Nicholas E.S. Sibinga, Hong Wang, Mark A. Perrella, Wilson O. Endege, Cam Patterson, Masao Yoshizumi, Edgar Haber, Mu En Lee

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Interferons (IFNs) affect cellular functions by altering gene expression. The eukaryotic cell cycle is governed in part by the periodic transcription of cyclin genes, whose protein products associate with and positively regulate the cyclin-dependent kinases. To understand better the growth inhibitory effect of IFN-γ on vascular smooth muscle cells (VSMCs), we compared the expression and activity of G1 and S phase cyclins in control and IFN-γ-treated VSMCs. IFN-γ treatment did not inhibit the G1 cyclins but did decrease cyclin A protein, mRNA, and associated kinase activity by 85, 90, and 90%, respectively. Nuclear run-on and mRNA stability determinations indicated that this decrease was the result of transcriptional inhibition. To investigate the molecular basis of this inhibition, we examined protein-DNA interactions involving the cyclin A promoter. Electromobility shift assays showed little change with IFN-y treatment in the binding of nuclear proteins to isolated γ, N-F-Y, and CDE elements. In vivo genomic footprinting indicated that IFN-γ treatment changed the occupancy of chromosomal NF-Y and CDE sites slightly and did not affect occupancy of the ATF site. In a previous study of transforming growth factor-β1-mediated inhibition of the cyclin A promoter, we mapped the inhibitory effect to the ATF site; in the present study of IFN-γ treatment, functional analysis by transient transfection showed that inhibition of the cyclin A promoter persisted despite mutation of the ATF, NF-Y, or CDE elements. We hypothesize that FN-γ inhibits cyclin A transcription by modifying co-activators or general transcription factors within the complex that drives transcription of the cyclin A gene.

Original languageEnglish (US)
Pages (from-to)12139-12146
Number of pages8
JournalJournal of Biological Chemistry
Volume274
Issue number17
DOIs
StatePublished - Apr 23 1999
Externally publishedYes

Fingerprint

Cyclin A
Cyclins
Transcription
Interferons
Genes
Cells
Vascular Smooth Muscle
Smooth Muscle Myocytes
Muscle
Cyclin G1
General Transcription Factors
Functional analysis
Messenger RNA
Proteins
Cyclin-Dependent Kinases
RNA Stability
G1 Phase
Transforming Growth Factors
Eukaryotic Cells
Nuclear Proteins

ASJC Scopus subject areas

  • Biochemistry

Cite this

Interferon-γ-mediated inhibition of cyclin A gene transcription is independent of Individual cis-acting elements in the cyclin a promoter. / Sibinga, Nicholas E.S.; Wang, Hong; Perrella, Mark A.; Endege, Wilson O.; Patterson, Cam; Yoshizumi, Masao; Haber, Edgar; Lee, Mu En.

In: Journal of Biological Chemistry, Vol. 274, No. 17, 23.04.1999, p. 12139-12146.

Research output: Contribution to journalArticle

Sibinga, Nicholas E.S. ; Wang, Hong ; Perrella, Mark A. ; Endege, Wilson O. ; Patterson, Cam ; Yoshizumi, Masao ; Haber, Edgar ; Lee, Mu En. / Interferon-γ-mediated inhibition of cyclin A gene transcription is independent of Individual cis-acting elements in the cyclin a promoter. In: Journal of Biological Chemistry. 1999 ; Vol. 274, No. 17. pp. 12139-12146.
@article{0df238ae44c34262aa08ab81aaeb0cf3,
title = "Interferon-γ-mediated inhibition of cyclin A gene transcription is independent of Individual cis-acting elements in the cyclin a promoter",
abstract = "Interferons (IFNs) affect cellular functions by altering gene expression. The eukaryotic cell cycle is governed in part by the periodic transcription of cyclin genes, whose protein products associate with and positively regulate the cyclin-dependent kinases. To understand better the growth inhibitory effect of IFN-γ on vascular smooth muscle cells (VSMCs), we compared the expression and activity of G1 and S phase cyclins in control and IFN-γ-treated VSMCs. IFN-γ treatment did not inhibit the G1 cyclins but did decrease cyclin A protein, mRNA, and associated kinase activity by 85, 90, and 90{\%}, respectively. Nuclear run-on and mRNA stability determinations indicated that this decrease was the result of transcriptional inhibition. To investigate the molecular basis of this inhibition, we examined protein-DNA interactions involving the cyclin A promoter. Electromobility shift assays showed little change with IFN-y treatment in the binding of nuclear proteins to isolated γ, N-F-Y, and CDE elements. In vivo genomic footprinting indicated that IFN-γ treatment changed the occupancy of chromosomal NF-Y and CDE sites slightly and did not affect occupancy of the ATF site. In a previous study of transforming growth factor-β1-mediated inhibition of the cyclin A promoter, we mapped the inhibitory effect to the ATF site; in the present study of IFN-γ treatment, functional analysis by transient transfection showed that inhibition of the cyclin A promoter persisted despite mutation of the ATF, NF-Y, or CDE elements. We hypothesize that FN-γ inhibits cyclin A transcription by modifying co-activators or general transcription factors within the complex that drives transcription of the cyclin A gene.",
author = "Sibinga, {Nicholas E.S.} and Hong Wang and Perrella, {Mark A.} and Endege, {Wilson O.} and Cam Patterson and Masao Yoshizumi and Edgar Haber and Lee, {Mu En}",
year = "1999",
month = "4",
day = "23",
doi = "10.1074/jbc.274.17.12139",
language = "English (US)",
volume = "274",
pages = "12139--12146",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "17",

}

TY - JOUR

T1 - Interferon-γ-mediated inhibition of cyclin A gene transcription is independent of Individual cis-acting elements in the cyclin a promoter

AU - Sibinga, Nicholas E.S.

AU - Wang, Hong

AU - Perrella, Mark A.

AU - Endege, Wilson O.

AU - Patterson, Cam

AU - Yoshizumi, Masao

AU - Haber, Edgar

AU - Lee, Mu En

PY - 1999/4/23

Y1 - 1999/4/23

N2 - Interferons (IFNs) affect cellular functions by altering gene expression. The eukaryotic cell cycle is governed in part by the periodic transcription of cyclin genes, whose protein products associate with and positively regulate the cyclin-dependent kinases. To understand better the growth inhibitory effect of IFN-γ on vascular smooth muscle cells (VSMCs), we compared the expression and activity of G1 and S phase cyclins in control and IFN-γ-treated VSMCs. IFN-γ treatment did not inhibit the G1 cyclins but did decrease cyclin A protein, mRNA, and associated kinase activity by 85, 90, and 90%, respectively. Nuclear run-on and mRNA stability determinations indicated that this decrease was the result of transcriptional inhibition. To investigate the molecular basis of this inhibition, we examined protein-DNA interactions involving the cyclin A promoter. Electromobility shift assays showed little change with IFN-y treatment in the binding of nuclear proteins to isolated γ, N-F-Y, and CDE elements. In vivo genomic footprinting indicated that IFN-γ treatment changed the occupancy of chromosomal NF-Y and CDE sites slightly and did not affect occupancy of the ATF site. In a previous study of transforming growth factor-β1-mediated inhibition of the cyclin A promoter, we mapped the inhibitory effect to the ATF site; in the present study of IFN-γ treatment, functional analysis by transient transfection showed that inhibition of the cyclin A promoter persisted despite mutation of the ATF, NF-Y, or CDE elements. We hypothesize that FN-γ inhibits cyclin A transcription by modifying co-activators or general transcription factors within the complex that drives transcription of the cyclin A gene.

AB - Interferons (IFNs) affect cellular functions by altering gene expression. The eukaryotic cell cycle is governed in part by the periodic transcription of cyclin genes, whose protein products associate with and positively regulate the cyclin-dependent kinases. To understand better the growth inhibitory effect of IFN-γ on vascular smooth muscle cells (VSMCs), we compared the expression and activity of G1 and S phase cyclins in control and IFN-γ-treated VSMCs. IFN-γ treatment did not inhibit the G1 cyclins but did decrease cyclin A protein, mRNA, and associated kinase activity by 85, 90, and 90%, respectively. Nuclear run-on and mRNA stability determinations indicated that this decrease was the result of transcriptional inhibition. To investigate the molecular basis of this inhibition, we examined protein-DNA interactions involving the cyclin A promoter. Electromobility shift assays showed little change with IFN-y treatment in the binding of nuclear proteins to isolated γ, N-F-Y, and CDE elements. In vivo genomic footprinting indicated that IFN-γ treatment changed the occupancy of chromosomal NF-Y and CDE sites slightly and did not affect occupancy of the ATF site. In a previous study of transforming growth factor-β1-mediated inhibition of the cyclin A promoter, we mapped the inhibitory effect to the ATF site; in the present study of IFN-γ treatment, functional analysis by transient transfection showed that inhibition of the cyclin A promoter persisted despite mutation of the ATF, NF-Y, or CDE elements. We hypothesize that FN-γ inhibits cyclin A transcription by modifying co-activators or general transcription factors within the complex that drives transcription of the cyclin A gene.

UR - http://www.scopus.com/inward/record.url?scp=0033597314&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033597314&partnerID=8YFLogxK

U2 - 10.1074/jbc.274.17.12139

DO - 10.1074/jbc.274.17.12139

M3 - Article

VL - 274

SP - 12139

EP - 12146

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 17

ER -